The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Telik, Inc.

Telik, Inc.
Nasdaq: TELK
Change
symbol:
     
 NEWS FROM THE WIRES
Telik Inc files for 4 million share offering
Aug 17 2001 05:25 PM PDT

More WIRE STORIES about this company

 PROFILE
Go Telik on the mountain: Telik discovers new drugs, focusing mainly on new treatments for cancer, diabetes, inflammatory diseases, and stroke. The company uses its proprietary Target-Related Affinity Profiling (TRAP) technology to identify potential drug compounds by analyzing the way they interact with proteins. Lead drug candidate TLK286 targets chemotherapy-resistant tumors, while TLK199 stimulates bone marrow to fight blood disorders. Telik has research and development agreements with such companies as Sanwa Kagaku Kenkyusho (a unit of Japanese drugmaker Suzuken), Sankyo, COR Therapeutics, and Scios. Sanwa, which holds Asian marketing rights to some of Telik's drug candidates, owns about 10% of the firm.

 COMPETITION
Amgen Inc. (AMGN)
Novo Nordisk A/S (NVO)
Regeneron Pharmaceuticals, Inc. (REGN)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 2.80
1-Yr. Sales Growth: (33.3)%
Employees: 43
Revenue per employee: $65,116.28

 KEY PEOPLE
• Michael M. Wick
    CEO
• Cynthia M. Butitta
    CFO

 CONTACT INFO
750 Gateway Blvd.
South San Francisco, CA 94080
US
Phone: 650-244-9303
Fax: 650-244-9388
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001